128 related articles for article (PubMed ID: 28017662)
1. Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Na
Lee SJ; Kim DH; Hahn SJ; Waxman SG; Choi JS
Neurosci Lett; 2017 Feb; 639():1-7. PubMed ID: 28017662
[TBL] [Abstract][Full Text] [Related]
2. Trifluoperazine blocks the human cardiac sodium channel, Na
Kim DH; Lee SJ; Hahn SJ; Choi JS
Biochem Biophys Res Commun; 2016 Oct; 479(3):584-589. PubMed ID: 27666479
[TBL] [Abstract][Full Text] [Related]
3. Norquetiapine blocks the human cardiac sodium channel Na
Kim DH; Park KS; Park SH; Hahn SJ; Choi JS
Eur J Pharmacol; 2020 Oct; 885():173532. PubMed ID: 32882214
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
Wang Y; Mi J; Lu K; Lu Y; Wang K
PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
[TBL] [Abstract][Full Text] [Related]
5. μ-conotoxin TsIIIA, a peptide inhibitor of human voltage-gated sodium channel hNa
Yang M; Zhou M
Toxicon; 2020 Oct; 186():29-34. PubMed ID: 32758497
[TBL] [Abstract][Full Text] [Related]
6. Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin.
Zhao F; Li X; Jin L; Zhang F; Inoue M; Yu B; Cao Z
Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26891306
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the inhibition of the fast inactivation of voltage-gated sodium channel Nav1.5 by tarantula toxin Jingzhaotoxin-II.
Huang Y; Zhou X; Tang C; Zhang Y; Tao H; Chen P; Liu Z
Peptides; 2015 Jun; 68():175-82. PubMed ID: 25817910
[TBL] [Abstract][Full Text] [Related]
8. Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.
Sun JF; Xu YJ; Kong XH; Su Y; Wang ZY
Neurosci Lett; 2019 Mar; 696():67-73. PubMed ID: 30528877
[TBL] [Abstract][Full Text] [Related]
9. Functionalized Fullerene Targeting Human Voltage-Gated Sodium Channel, hNa
Hilder TA; Robinson A; Chung SH
ACS Chem Neurosci; 2017 Aug; 8(8):1747-1755. PubMed ID: 28586206
[TBL] [Abstract][Full Text] [Related]
10. Investigation into the role of an extracellular loop in mediating proton-evoked inhibition of voltage-gated sodium channels.
Harms E; Stoetzer C; Stueber T; O'Reilly AO; Leffler A
Neurosci Lett; 2017 Nov; 661():5-10. PubMed ID: 28939386
[TBL] [Abstract][Full Text] [Related]
11. Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7.
Zhang XY; Bi RY; Zhang P; Gan YH
Acta Pharmacol Sin; 2018 Nov; 39(11):1716-1724. PubMed ID: 29950616
[TBL] [Abstract][Full Text] [Related]
12. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
[TBL] [Abstract][Full Text] [Related]
13. The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes.
Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Sata T
Anesth Analg; 2014 Mar; 118(3):554-62. PubMed ID: 24557103
[TBL] [Abstract][Full Text] [Related]
14. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
15. Benzonatate inhibition of voltage-gated sodium currents.
Evans MS; Maglinger GB; Fletcher AM; Johnson SR
Neuropharmacology; 2016 Feb; 101():179-87. PubMed ID: 26386152
[TBL] [Abstract][Full Text] [Related]
16. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
[TBL] [Abstract][Full Text] [Related]
17. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
Wang GK; Wang SY
Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants inhibit Na
Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Sata T; Kawasaki T
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1255-1270. PubMed ID: 28905186
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models.
Ghelardini C; Desaphy JF; Muraglia M; Corbo F; Matucci R; Dipalma A; Bertucci C; Pistolozzi M; Nesi M; Norcini M; Franchini C; Camerino DC
Neuroscience; 2010 Aug; 169(2):863-73. PubMed ID: 20580661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
